94 related articles for article (PubMed ID: 8913508)
1. Effects of atropine and loperamide on the agitating force and GI transit time in dogs in drug absorption studies.
Katori N; Aoyagi N; Kojima S
Biol Pharm Bull; 1996 Oct; 19(10):1338-40. PubMed ID: 8913508
[TBL] [Abstract][Full Text] [Related]
2. Effects of codeine on the agitating force and gastrointestinal transit time in dogs, for use in drug absorption studies.
Katori N; Aoyagi N; Kojima S
Biol Pharm Bull; 1998 Apr; 21(4):418-20. PubMed ID: 9586586
[TBL] [Abstract][Full Text] [Related]
3. Tracking gastrointestinal transit of solids in aged rats as pharmacological models of chronic dysmotility.
Dalziel JE; Young W; Bercik P; Spencer NJ; Ryan LJ; Dunstan KE; Lloyd-West CM; Gopal PK; Haggarty NW; Roy NC
Neurogastroenterol Motil; 2016 Aug; 28(8):1241-51. PubMed ID: 27028044
[TBL] [Abstract][Full Text] [Related]
4. Using pharmacokinetic modeling to determine the effect of drug and food on gastrointestinal transit in dogs.
Sjödin L; Visser S; Al-Saffar A
J Pharmacol Toxicol Methods; 2011; 64(1):42-52. PubMed ID: 21596146
[TBL] [Abstract][Full Text] [Related]
5. Effect of small intestinal transit time on gastrointestinal absorption of 2-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl ] ethyl acetate, a new non-steroidal anti-inflammatory agent.
Mizuta H; Kawazoe Y; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2825-8. PubMed ID: 2076568
[TBL] [Abstract][Full Text] [Related]
6. Effect of loperamide on jejunal electrolyte and water transport, prostaglandin E2-induced secretion and intestinal transit time in man.
Press AG; Ewe K; Schmidt J; Junge H
Eur J Clin Pharmacol; 1991; 41(3):239-43. PubMed ID: 1748140
[TBL] [Abstract][Full Text] [Related]
7. Absorptive and motor components of the antidiarrhoeal action of loperamide: an in vivo study in pigs.
Théodorou V; Fioramonti J; Hachet T; Buéno L
Gut; 1991 Nov; 32(11):1355-9. PubMed ID: 1752468
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the non-invasive faecal pellet assessment method as an early drug discovery screen for gastrointestinal liability.
Marks L; Beard E; Cobey D; Moore N; Motyer V; Valentin JP; Ewart L
J Pharmacol Toxicol Methods; 2013; 68(1):123-36. PubMed ID: 23542059
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two models of drug-induced constipation in mice and evaluation of mustard oil in these models.
Kojima R; Doihara H; Nozawa K; Kawabata-Shoda E; Yokoyama T; Ito H
Pharmacology; 2009; 84(4):227-33. PubMed ID: 19752586
[TBL] [Abstract][Full Text] [Related]
10. Agarwood induced laxative effects via acetylcholine receptors on loperamide-induced constipation in mice.
Kakino M; Izuta H; Ito T; Tsuruma K; Araki Y; Shimazawa M; Oyama M; Iinuma M; Hara H
Biosci Biotechnol Biochem; 2010; 74(8):1550-5. PubMed ID: 20699592
[TBL] [Abstract][Full Text] [Related]
11. Loperamide: a pharmacological review.
Baker DE
Rev Gastroenterol Disord; 2007; 7 Suppl 3():S11-8. PubMed ID: 18192961
[TBL] [Abstract][Full Text] [Related]
12. Development of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in mice.
Tan-No K; Niijima F; Nakagawasai O; Sato T; Satoh S; Tadano T
Eur J Pharm Sci; 2003 Nov; 20(3):357-63. PubMed ID: 14592702
[TBL] [Abstract][Full Text] [Related]
13. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation.
Katori N; Aoyagi N; Terao T
Pharm Res; 1995 Feb; 12(2):237-43. PubMed ID: 7784339
[TBL] [Abstract][Full Text] [Related]
14. Effect of loperamide and bisacodyl on intestinal transit time, fecal weight and short chain fatty acid excretion in the rat.
Bustos D; Ogawa K; Pons S; Soriano E; Bandi JC; Bustos Fernández L
Acta Gastroenterol Latinoam; 1991; 21(1):3-9. PubMed ID: 1811403
[TBL] [Abstract][Full Text] [Related]
15. Loperamide abolishes exercise-induced orocecal liquid transit acceleration.
Keeling WF; Harris A; Martin BJ
Dig Dis Sci; 1993 Oct; 38(10):1783-7. PubMed ID: 8404397
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal transit monitoring and absorption of controlled-release pellets of diltiazem.
Rahman NU; Yuen KH; Woei WJ
Pharm Dev Technol; 2005; 10(3):371-9. PubMed ID: 16176017
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal absorption of chlorothiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog.
Mizuta H; Kawazoe Y; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2810-3. PubMed ID: 1981694
[TBL] [Abstract][Full Text] [Related]
18. Effect of codeine and loperamide on upper intestinal transit and absorption in normal subjects and patients with postvagotomy diarrhoea.
O'Brien JD; Thompson DG; McIntyre A; Burnham WR; Walker E
Gut; 1988 Mar; 29(3):312-8. PubMed ID: 3356363
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule.
Koziolek M; Grimm M; Bollmann T; Schäfer KJ; Blattner SM; Lotz R; Boeck G; Weitschies W
Eur J Pharm Biopharm; 2019 Mar; 136():221-230. PubMed ID: 30703546
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro and in vivo performance of a colonic delivery system.
Ahmed IS; Ayres JW
Int J Pharm; 2011 May; 409(1-2):169-77. PubMed ID: 21382462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]